Direct oral anticoagulant therapy in patients with morbid obesity after intermediate- or high-risk pulmonary emboli

Direct oral anticoagulant therapy in patients with morbid obesity after intermediate- or high-risk pulmonary emboli

There is little reported on the efficacy and safety of direct oral anticoagulants (DOACs) in morbid obesity after venous thromboembolism (VTE). In this observational study, patients were followed up after intermediate- or high-risk pulmonary embolism (PE) at the University of Rochester Pulmonary Hyp...

Full description

Bibliographic Details
Main Authors: Daniel J. Lachant, Christina Bach, Alexander Fe, R. James White, Neil A. Lachant
Format: Article
Language:English
Published: European Respiratory Society 2021-02-01
Series:ERJ Open Research
Online Access:http://openres.ersjournals.com/content/7/1/00554-2020.full

Similar Items

Similar Items